Medgenesis Therapeutix Inc

Medgenesis Therapeutix Inc is a private Canadian biopharmaceutical holding company based in Victoria, Canada, specializing in properties within the neurological space. With a focus on Parkinson's disease, Medgenesis has been involved in the clinical development of innovative treatments, including the glial cell line derived neurotrophic factor (GDNF) program.

Recently, Medgenesis sold the GDNF program to Vivifi Biotech Ltd, a subsidiary of the Parkinson's Society of the United Kingdom, while retaining a significant economic interest in the program. The company continues to support the program's development through the sale of other critical intellectual property assets, with a commitment to potential commercialization pending positive clinical results.

Generated from their website